CXCL12 and cancer: Liu et al. demonstrated that hypoxia enhances CXCR4-mediated metastasis via HIF-1α and HIF-2α activation, promoting cancer cell adhesion, movement, and invasion in response to CXCL12, indicating that targeting CXCR4 alongside hypoxia pathways may provide novel therapeutic strategies (Liu et al., 2006).